| Entry |
|
| Name |
Repifermin (USAN/INN) |
| Formula |
C723H1131N209O204S5
|
| Exact mass |
16165.3155
|
| Mol weight |
16175.33
|
| Sequence |
SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTKKENCPY SILEITSVEI GVVAVKAINS NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN WQHNGRQMYV ALNGKGAPRR GQKTRRKNTS AHFLPMVVHS |
| Type |
Peptide |
| Efficacy |
Anti-inflammatory, Wound healing |
| Comment |
Treatment of mucositis and to promote wound healing
33-172-Keratinocyte growth factor 2 [HSA: 2255] [KO: K04358]
|
| Target |
|
| Pathway |
| hsa04550 | Signaling pathways regulating pluripotency of stem cells |
| hsa04810 | Regulation of actin cytoskeleton |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
FGFR family
FGFR
D05716 Repifermin (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|